Christina Pistilli, MD
Internal Medicine · Lexington, KYNPI 1235717745
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 61 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 14.5% — the pattern of someone who eats at a lot of different presentations.
Across 61 payments — averaging $17.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$157
- GSK$105
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$92
- Gilead$79
- AbbVie$77
- Bayer$63
- plus $508 from 16 others
What the payments were for
- Food & beverage$1,081100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 10 | $157 |
| GSK | 6 | $105 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $92 |
| Gilead | 4 | $79 |
| AbbVie | 4 | $77 |
| Bayer | 4 | $63 |
| Novo Nordisk | 3 | $59 |
| Ardelyx, Inc. | 3 | $54 |
| Astellas Pharma US Inc | 3 | $49 |
| Pfizer | 3 | $47 |
| Sanofi-aventis U.S. LLC | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Phathom Pharmaceuticals, Inc. | 2 | $36 |
| Exact Sciences | 2 | $29 |
| Dexcom, Inc. | 1 | $28 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Boehringer Ingelheim | 1 | $21 |
| Dynavax Technologies Corporation | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Cranial Technologies, Inc | 1 | $16 |
| Amgen | 1 | $15 |
| AstraZeneca | 1 | $14 |
How this compares
$1,081 in reported general payments places this provider in the 65th percentile of 1,284 internal medicine providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 55 | $568 |
| Duloxetine Hcl | 14 | $333 |
| Rosuvastatin Calcium | 27 | $238 |
| Omeprazole | 25 | $221 |
| Sertraline Hcl | 19 | $213 |
| Pravastatin Sodium | 11 | $212 |
| Lisinopril | 24 | $175 |
| Levothyroxine Sodium | 23 | $174 |
| Losartan Potassium | 12 | $87 |
| Spironolactone | 12 | $85 |
| Amlodipine Besylate | 20 | $68 |
| Trazodone Hcl | 19 | $67 |
| Furosemide | 16 | $30 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Lexington
- David ManninoLexington$168K
- Fadi BachaLexington$31K
- Jad BalloutLexington$30K
- Thomas von UnrugLexington$22K
- Danilo CoralesLexington$17K
- Mohamed TashaniLexington$17K
- Kelli TrentLexington$16K
- Richard BeltLexington$14K
- Coutney SchniedersLexington$12K
- Fares KhaterWhitesburg$412K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.